SIX:BSLN
Basilea Pharmaceutica AG · SIX · Healthcare · CHF · FY for 2025
Figures on this page computed 2026-11-08 10:27 UTC
Last close
n/aCHF
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
21.6xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- computed
- Computed from the filing for 2025
24.2%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
17.3%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
25.5%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
0.70Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- computed
Growth is the furthest below its sector's middle: 0.43 against 0.50 on the market's range.
- Growth12.7%43 of 100, below its sector
- Returns on capital24.2%92 of 100, above its sector
- Margins83.1%88 of 100, above its sector
- Price21.6x31 of 100, below its sector
- Safety0.7062 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.60x
Its own average over 10 years, 145.7M.
- Profit-72.00x
Its own average over 10 years, -558.3K.
- Free cash flow-4.19x
Its own average over 10 years, -14.1M.
- Debt0.51x
Its own average over 10 years, 176.4M.
- Pricen/a
Its own average over 0 years. Market data
Profit is furthest from its own average, at -72.00 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Shares in issue |
|---|---|---|
| 2016-12-31 | 100.0 | 100.0 |
| 2017-12-31 | 153.9 | 107.2 |
| 2018-12-31 | 200.9 | 107.1 |
| 2019-12-31 | 203.7 | 106.3 |
| 2020-12-31 | 193.4 | 101.6 |
| 2021-12-31 | 224.5 | 115.4 |
| 2022-12-31 | 223.9 | 118.0 |
| 2023-12-31 | 238.9 | 120.0 |
| 2024-12-31 | 316.1 | 136.9 |
| 2025-12-31 | 352.2 | 126.5 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CHF
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CHF
Figures behind the shape
Growth
12.7%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate12.7%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- computed
One-year change in net income-48.2%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- computed
Returns on capital
24.2%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital24.2%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity31.4%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets14.3%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
83.1%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin83.1%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin22.2%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin17.3%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin25.5%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
21.6xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings21.6x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- computed
- Computed from the filing for 2025
Price to book7.1x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA18.1x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio3.9x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
0.70safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equity0.70
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio5.11
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage15.4x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score1.45
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
n/aWe do not hold this figure for this company, so there is nothing to place.
more, and better covered, is higher, with no cohort held
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CHF
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.